- Home
- CELC vs PSTL Comparison
CELC vs PSTL Comparison
Compare CELC & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- PSTL
- Stock Information
- Founded
- CELC 2011
- PSTL 2018
- Country
- CELC United States
- PSTL United States
- Employees
- CELC N/A
- PSTL N/A
- Industry
- CELC Medical Specialities
- PSTL Real Estate Investment Trusts
- Sector
- CELC Health Care
- PSTL Real Estate
- Exchange
- CELC Nasdaq
- PSTL Nasdaq
- Market Cap
- CELC 391.0M
- PSTL 335.6M
- IPO Year
- CELC 2017
- PSTL 2019
- Fundamental
- Price
- CELC $10.11
- PSTL $14.30
- Analyst Decision
- CELC Strong Buy
- PSTL Strong Buy
- Analyst Count
- CELC 6
- PSTL 1
- Target Price
- CELC $30.17
- PSTL $15.50
- AVG Volume (30 Days)
- CELC 248.4K
- PSTL 176.8K
- Earning Date
- CELC 03-31-2025
- PSTL 05-06-2025
- Dividend Yield
- CELC N/A
- PSTL 6.81%
- EPS Growth
- CELC N/A
- PSTL 83.16
- EPS
- CELC N/A
- PSTL 0.21
- Revenue
- CELC N/A
- PSTL $76,372,000.00
- Revenue This Year
- CELC $49.98
- PSTL $9.86
- Revenue Next Year
- CELC N/A
- PSTL $10.76
- P/E Ratio
- CELC N/A
- PSTL $65.98
- Revenue Growth
- CELC N/A
- PSTL 19.87
- 52 Week Low
- CELC $8.53
- PSTL $12.26
- 52 Week High
- CELC $22.04
- PSTL $15.15
- Technical
- Relative Strength Index (RSI)
- CELC 43.41
- PSTL 59.35
- Support Level
- CELC $9.98
- PSTL $13.95
- Resistance Level
- CELC $10.70
- PSTL $14.23
- Average True Range (ATR)
- CELC 0.68
- PSTL 0.25
- MACD
- CELC 0.06
- PSTL -0.03
- Stochastic Oscillator
- CELC 28.38
- PSTL 75.20
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.